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SUMMARY 
The physical properties of crystalline B-streptomycin salts 
differ from those of the corresponding amorphous cv-streptomycin salts, 
although both forms show no spectral evidence for the aldehyde group 
in the streptose portion of the molecule. It had been suggested pre­
viously that this aldehyde group is linked to various -OH groups in a 
hemiacetal formation in the cv-salts to the nitrogen of the aminomethyl 
group of the N-methyl-L-glucosamine part of the molecule in the B-salts. 
No experimental evidence had been recorded to substantiate this sugges­
tion. The purpose of this research was to establish the nature of the 
hemiacetal linkage of the potentially-free aldehyde group in the B-
streptomycin salts. 
The first approach to determine the structure of B-streptomycin 
salts by X-ray diffraction studies had to be abandoned because these 
salts were found to exist as liquid crystals and hence were unsuitable 
for X-ray diffraction studies. 
Earlier work on the structure of dihydrostreptobiosamine had 
shown that the potentially-free aldehyde group in that molecule was 
linked with the nitrogen of the aminomethyl group of N-methyl-L-glucos­
amine. This was demonstrated by hydrogenolysis of dihydrostreptobios­
amine. The resulting product, after acetylation, was found to be a 
pentaacetyl basic compound, instead of a heptaacetyl neutral compound. 
This was explained on the basis that the N-hemiacetal bond was hydro-
genolyzed, yielding a morpholine derivative. Extending this analogy to 
Xll 
P-streptomycin salts, one would expect an azoxepine type of structure 
on reduction of p-streptomycin. This could be differentiated from the 
ordinary a-dihydrostreptomycin by the N-carbobenzoxylation of the amino-
methyl nitrogen under suitable conditions. The product obtained on 
such a reduction of P-streptomycin trihydrochloride showed a 25-50 per­
cent N-carbobenzoxylation under conditions that gave 100 percent N-
carbobenzoxylation of o/-dihydrostreptomycin. This showed that there was 
75-50 percent conversion to p-dihydrostreptomycin by reduction of 
crystalline P-streptomycin salts. The exact amount of this conversion 
varied from preparation to preparation. 
Various chromatographic techniques to purify the crude p-dihydro-
streptomycin (from o/-dihydrostreptomycin and N-carbobenzoxy-o/-dihydro-
streptomycin) did not give a pure compound. Countercurrent distribution 
of the mixture of N-carbobenzoxy-a-dihydrostreptomycin and P-dihydro-
streptomycin in 1-butanol and 5 percent aqueous p-toluenesulfonic acid 
gave pure p-dihydrostreptomycin in the lower phase. This compound was 
characterized by cleavage to streptidine on acid hydrolysis, by its 
specific rotation, and by its R^ , values on chromatography (from those 
of the o/-dihydrostreptomycin). Beta-dihydrostreptomycin was also found 
to be biologically inactive. 
Thus, it has been established that in p-streptomycin the potentially 
free aldehyde in the streptose fragment is linked to the aminomethyl 
nitrogen of the N-methyl-L-glucosamine part of the streptomycin molecule. 
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CHAPTER I 
INTRODUCTION 
Streptomycin was isolated in 1 9 ^ by Waksman and co-workers from 
cultures of Streptomyces griseus, an organism of the order Actinomy-
cetales (l). The antibiotic was found to have low toxicity, potent 
therapeutic action, and was the object of intensive research soon after 
its discovery (2). The substance was found to be effective against a 
wide variety of microorganisms and was the first drug used effectively 
against tuberculosis. Streptomycin has also been employed successfully 
in the treatment of diseases such as leprosy, tularemia, typhoid, and 
brucellois (2,3). The clinical aspects of• this antibiotic have been 
reviewed (2). 
Purification of crude streptomycin was a major problem and was 
achieved by precipitation with picric acid and conversion of the picrate 
to the hydrochloride (U). Also, crude streptomycin was chromatographed 
over acid-washed alumina using methanol as the eluant ( 5 ) . Conversion 
of streptomycin to the trihelianthate salt and then reconverting that 
salt to the trihydrochloride salt also achieved purification (U ,5 ,6 ) . 
Determination of Structure 
Extensive research established the structure of streptomycin as 
that shown by structure I (8). Many excellent reviews of the literature 
on the structure of streptomycin exist (2,7,8). The molecular formula 
of streptomycin has been shown- to be C„,H_QNr70 It is a levorotatory, 
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tribasic compound that is unstable in aqueous solution. It was readily 
converted to maltol on warming in the presence of dilute alkali. On 
hydrogenation at atmospheric pressure, using platinum or palladium as 
the catalyst, streptomycin trihydrochloride absorbed one equivalent of 
hydrogen. The product, dihydrostreptomycin trihydrochloride, differed 
but slightly from streptomycin trihydrochloride in its biological 
activity, a very unusual occurrence, since even a slight change in the 
structure of most antibiotics result in marked variation in their 
activities. Later, dihydrostreptomycin was isolated as a major fermen­
tation product of streptomyces humidus (9). 
Streptomycin formed oxime and semicarbazone derivatives, which 
3 
were biologically inactive; dihydrostreptomycin, however, gave no such 
derivatives. Because streptomycin showed no spectral evidence for the 
presence of a free carbonyl group, a potentially free carbonyl group 
was indicated from the above evidence (2,10). 
Degradation of streptomycin with methanolic hydrogen chloride 
yielded two compounds, which were streptidine dihydrochloride (ii) and 
methyl streptobiosaminide dimethyl acetal hydrochloride (ill) (11,12). 
Streptomycin 
Trihydrochloride 
HC1 
C 2 l H 3 9 V l 2 ' 3 H C 1 r w n f f > C8 Hl6 W6°U • 2 H C 1 <"> + 
C 1 3 H 2 2 W 0 7 ( 0 C H 3 ) 2 * H C 1 
Streptidine was shown to be l,3-diguanidino-2,U,5,6-tetrahydroxycyclo-
hexane; all the functional groups were equatorial (2,13,lU,15). The 
hydroxyl group of streptidine was attached to the streptobiosamine moiety. 
Streptidine has been synthesized (15), and the absolute stereochemistry 
of the six asymmetric carbon atoms of streptidine in the streptomycin 
molecule has been established (l6). The absence of a free or potentially 
free carbonyl group in streptidine indicated that the carbonyl group 
resides in the streptobiosamine moiety and is converted to a dimethyl 
acetal derivative upon acidic methanolysis. 
Using bromine water, streptomycin can be oxidized to an acid 
called streptomycenic acid, which has the same number of carbon atoms 
as streptomycin (5). This fact led to the inference that the potentially 
free carbonyl function in streptomycin is an aldehyde. 
The mercaptolysis of streptomycin gave streptidine and another 
k 
product, which was identified as ethyl thiostreptobiosaminide dithio-
acetal (IV) (17). This also confirmed the presence of a potential 
aldehyde group in the streptobiosamine fragment and also indicated that 
streptidine is linked glycosidically to another aldehyde function in the 
streptobiosamine fragment (2,l8). 
Streptomycin HCI 
Trihydrochloride > 1 + C ^ ^ S ^ • HCI (IV) 
CgH^SH 
When methyl streptobiosaminide dimethyl acetal hydrochloride (ill) 
was treated with aqueous acid and the resulting crude product was ace-
tylated, a compound resulted that had the molecular formula C^^Hg^NO^. 
The formula was consistent for a pentaacetyl N-methylhexosamine, which 
by subsequent tests and independent synthesis was identified as the 
pentaacetyl derivative of N-methyl-L-glucosamine (38). This further led 
to the conclusion that the potentially free aldehyde group was present 
in the streptose moiety. Streptose has the molecular formula C^H^O^ (19), 
and has been shown to have structure V, which has been confirmed by an 
independent synthesis (20). 
V 
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Tautomeric Forms of Streptomycin 
The potentially free aldehyde group in streptose has been, suggested 
to be linked with "various hydroxyl, amino, and guanidino functional 
groups. Titus and Fried (21), in their countercurrent distribution 
studies of streptomycin, observed that the antibiotic existed as a 
mixture of "tautomeric" modifications, the relative proportions of which 
depended upon pH. They indicated that such "tautomers"could at least 
partially be separated by chromatography on alumina. The tautomeric 
shift was dependent on the pH; an alkaline pH favored conversion to that 
"tautomer" that had a high distribution constant. 
In 1953, Heuser and co-workers (22) reported their studies on 
purification and crystallization of streptomycin. Streptomycin preci­
pitates with such general reagents as methyl orange, Reinecke acid, 
picric acid, and phosphotungstic acid. Until Heuser's observation no 
practical method had been found for obtaining crystalline streptomycin 
salts of simple mineral acids. These workers found that such commercially 
available wetting agents as Duponols and Tergitols could precipitate the 
basic antibiotics, and the metathesis of such precipitated salts provided 
an excellent means for the preparation of crystalline mineral acid salts 
of streptomycin. Tergitol-7, a sodium sulfate derivative of 3,9-diethyl-
tridecan-6-ol was found to give the best results for precipitating 
streptomycin at suitably controlled pH. These precipitates (hereafter 
called "tergitates"), after aging at 5° for a few days, could be 
crystallized. The crude tergitate was readily soluble in solvents like 
benzene, ether, chloroform, various alcohols, and aqueous acetone. In 
contrast, the crystalline tergitate was found to be difficultly soluble 
6 
in most organic solvents. The solubility was, of course, increased by 
addition of a small amount of water. 
Streptomycin of higher purity could be recovered from these 
alkyl sulfate salts of streptomycin by a variety of methods (23). Some 
of these methods were unsatisfactory in that some of the antibiotic de­
composed and some other undesirable impurities were added. One of the 
best methods to effect metathesis was by the addition of an inorganic 
acid to a solution of the streptomycin tergitate at a pH controlled by 
anion exchange resins. This method increased the biological potency of 
a given sample of crude streptomycin from an original 100-300 y/mg to 
650-700 y/mg. 
Heuser, et al.(22) also obtained crystalline trihalides, trini­
trate, sulfate, and phosphate salts of streptomycin from the methanolic 
solution of aged streptomycin tergitates. The trihydrochlorides and 
trinitrates were obtained by adding a dilute solution of the appropriate 
acid or calcium salt to the methanolic solution of the tergitates. Thus, 
in the reaction of methanolic calcium chloride with a methanolic solution 
of aged streptomycin tergitate, the crystalline trihydrochloride was ob­
tained. These workers did not observe a double salt of calcium chloride 
and streptomycin as has been reported by Folkers (2h). The trihydro-
halides were monoclinic crystals, which could be recrystallized from 
methanol with great difficulty. However, better yields in recrystalli-
zation were reported when a highly concentrated aqueous solution of the 
crystalline trihydrochloride, for example, was diluted with methanol or 
methanolic calcium chloride. If the aqueous solution of the crystalline 
salt was allowed to stand before diluting, the yield of the crystals 
7 
became considerably lower. 
Elemental analyses and ultraviolet and infrared spectral properties 
of the crystalline material were reported similar to the pure amorphous 
salts. 
The crystalline sulfate differed strikingly from the amorphous 
sulfate in solubility behavior. While the amorphous sulfate is readily 
soluble in water, the crystalline form is only sparingly soluble. The 
sulfate was crystallized by dissolving streptomycin tergitate in 1-butanol 
and mixing this solution with an aqueous solution of guanidine sulfate. 
The crystalline form of this streptomycin sulfate is rectangular prisms; 
analysis showed it to be a sesquisulfate. 
All the crystalline organic salts of streptomycin, like the 
crystalline tergitate, were obtained in optimum yield only after aging 
the crude tergitate for about one week at 5°. Furthermore, it was very 
difficult to recrystallize a once-crystallized salt that had been dis­
solved in aqueous solution for some time. These facts clearly indicated 
that these were "tautomeric forms" of streptomycin. Thus, the earlier 
observations of Titus and Fried (21) were confirmed. Heuser and co­
workers (22) further confirmed this hypothesis by a comparative study 
of the distribution constants of amorphous and crystalline streptomycin 
trihydrochloride in the system butanol-aqueous-p-toluenesulfonic acid. 
They observed the instability of the crystalline "tautomer" in aqueous 
solution and also that hydrochloric acid stabilized it. If the sample 
of the crystalline streptomycin was dissolved directly in the sulfonic 
acid phase before introduction into the butanol-p-toluenesulfonic acid 
system, a marked stabilization was observed. The amorphous form dis-
8 
played essentially the same value for K, as shown in Table 1. 
Table 1. Distribution Constants of Streptomycin Trihydro­
chloride Tautomers 
Solvent 
K for 1-Butanol-Water l-Butanol-0.01 N 
Hydrochloric Acid 
1-Butanol-
5 Percent 
Aqueous p-
toluene-
sulfonic acid 
crystals 1.30 11.1 15.0 
amorphous 0.97 1.05 1.01 
The rate of change in these solvents from the crystalline form 
to the amorphous form was studied by allowing the respective solutions 
to stand. Samples were withdrawn periodically for the determination 
of K. It was shown that conversion was almost instantaneous in a neu­
tral aqueous medium. 
Additional evidence of "tautomerism" and "tautomeric" change with 
the passage of time was provided by polargrams recorded from solutions 
of crystalline and amorphous streptomycin salts. The clearest evidence (25) 
that this phenomenon was not due to solvolysis or allotropy was that a 
solution of crystalline streptomycin trihydrochloride precipitated cry­
stalline streptomycin sulfate on the addition of sulfate ion. 
Young repeated and extended Heuser's work and designated the 
crystalline form as 3-streptomycin salts (26), using a-streptomycin to 
indicate the amorphous form. He obtained the biphenyl-U-sulfonate, the 
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5-cyclohexyl-2-hydroxy-3-methylbenzoate, and the 2-hydroxy-5-isobutyl-
3-methylbenzoate salts of S-streptomycin. In the case of the first two 
of these, the a-streptomycin salts are also crystalline. However, the 
a- and 8-pairs of these salts had different X-ray diffraction patterns. 
These three new salts were further converted into B-streptomycin sulfate. 
Young (26) also studied the conversion of B- to a-streptomycin 
salts polarimetrically and studied the effect of pH on this conversion. 
A methanol solution of B-streptomycin tergitate (50 mg/ml) showed a change 
of optical rotation at 20° from - 19 .8 ° to -26.k° in a few days. In 0 .01 
N-methanolic sodium hydroxide, the change in rotation was more rapid. 
However, in 0 .01 N-methanolic sulfuric acid, no measurable change in 
optical rotation was observed for 18 hours; in 0 . 1 N-methanolic acetic 
acid the change in optical rotation showed only 3 percent conversion into 
the a-form in 2k hours. The p-tergitate salt of streptomycin could be 
"stabilized" when recrystallized from methanol-water containing a trace 
of sulfuric acid, in that it showed no appreciable change of optical 
rotation in methanol solution. It did revert to the a-form if a trace 
of sodium hydroxide was added; this change was second-order in all cases. 
Similar changes were observed for B-streptomycin 5-cyclohexyl-2-
22 
hydroxy-3-methylbenzoate. The change was rather rapid and small; [a]^ 
was -82.3 10 minutes after preparation (50mg/ml) and changed to a 
final value of - 79 .1 ° (2k hours). Gravimetric assay of the p-form by 
precipitation as the sulfate salt gave identical results. Here again, 
the change was distinctly retarded by 0 .001 N-hydrochloric acid. 
Young also observed that the p-salts were solvated. The sulfate 
salt lost the equivalent of seven molecules of water when dried; the 
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dried salt was readily soluble in water, but the hydrated sulfate pre­
cipitated soon. The trihydrochloride was solvated with two molecules 
of methanol. Thus, the 3-streptomycin cation was shown to have the same 
composition as the corresponding a-streptomycin cation. These forms 
have sufficiently mobile interconversion to justify the term "tautomerism." 
The only other salt which on aging yields the crystalline 3-salts 
is the related U-ethyl-l-isobutyloctyl sulfate (Tergitol-U) ( 26 ) . 
It was also observed that an aqueous solution of a-streptomycin 
salts exhibited no detectable amount of the J3-form .in equilibrium. There 
was no change in rotation in solutions of a-streptomycin salts; no 3-
sulfate could be precipitated from the solutions of a-streptomycin by 
the addition of an excess of sulfate ions. It was therefore concluded 
that conversion to the 3-form could not occur in a solid phase in contact 
with a solvent containing appreciable amounts of dissolved streptomycin. 
The tergitate had the unique combination of properties, that is, it is 
insoluble in water but the presence of water is required to convert it 
into the 3-"tautomer." The driving force of this reaction was attributed 
presumably to the crystallization of the hydrate. 
Mannosido streptomycin shows the same phenomenon, but dihydro­
streptomycin and streptomycin oxime do not, which implies that the al­
dehyde group is involved in the structural change. Young (26) confirmed 
this by showing that 3-streptomycin tergitate, in methanolic 0 . 1 N 
acetic acid, reacted more slowly than the a-salt with hydroxylamine and 
U-phenylsemicarbazide. The reaction in both instances was followed 
polarimetrically. Thus, the aldehyde group in the 3-salts is combined 
in such a way as to be less reactive. The distinct influence of bases 
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on the 01 8 conversion is manifested at the neutralization point of 
the least basic ionizable group of the streptomycin cation. Young sug­
gested that the weakest basic group in the streptomycin molecule, i.e., 
the methylamino group, is concerned in this structural change. This 
group may combine with the aldehyde group to form a seven-membered ring 
that is sterically favored in the twist chair form (Vi). This kind of 
R = OH VI 
R = -H VII 
structure has an analogy in cotarnine, VIII (27). No serious non-bonded 
interaction would be expected from the structure suggested for g-strep-
tomyc in. 
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The alternative proposal that the aldehyde group could be linked 
with one of the guanidino nitrogens as a hemiacetal can be ruled out on 
the basis of steric hindrance. 
Purpose of the Research 
It was proposed to establish unequivocally the structure of (3-
streptomycin salts. The stability of the (3-salts in acidic medium 
seemed to indicate that these salts might have an N-hemiacetal structure: 
OH \ / . I 
\ / H I 1+ 
C = 0 + N— - > -C N — 
H N H H H 
The positive charge on nitrogen would hinder the approach of a hydronium 
ion at carbon, the first step in the hydrolysis of acetals and hemiace-
tals. Earlier work of Fried and co-workers (30) had shown that hydro-
genation of dihydrostreptobiosamine hydrochloride resulted in the uptake 
of one mole of hydrogen. The acetylation of the product yielded a 
crystalline derivative that was not heptaacetyltetrahydrostreptobiosamine, 
but a base hydrochloride C2gH200gN(CHgC0),- • HCI. Prior to acetylation, 
the product was non-reducing and did not give N-methyl-L-glucosamine on 
hydrolysis. These workers showed that the reduction of dihydrostrepto­
biosamine had given rise to the morpholine structure, IX, called tetra-
anhydrostreptobiosamine. Dihydrostreptobiosamine was shown to possess 
structure X. 
On the basis of this analogy, if (3-streptomycin salts have the 
N-hemiacetal structure VI, on catalytic hydrogenolysis it would be ex­
pected to yield a compound with structure VII, a tertiary amine. An 
13 
examination of Dreiding models reveals that no strain or unusual non-
bonding interaction exists in such a compound. Such a structure would 
not be expected to yield N-methyl-L-glucosamine on hydrolysis, but would 
give streptidine. 
3 
R = H IX 
R = -OH X 
On the other hand, if the aldehyde group of the streptose moiety 
formed a hemiacetal linkage with a nitrogen of the or guanidine 
units of streptidine (as suggested by Bricker and Vail (28), although 
subsequently discounted on the basis of steric hinderance (lO)), the 
catalytic hydrogenolysis would be expected to give a derivative with a 
disubstituted guanidine group. Upon acid hydrolysis of this compound, 
one would expect cleavage of N-methyl-L-gluosamine rather than of 
streptidine. 
It was proposed to subject the B-streptomycin salts to catalytic 
hydrogenation and to establish the nature of amino group in the result­
ing compound. This would, in turn, confirm the structure of B-strepto­
mycin salts. 
Ik 
CHAPTER II 
EXPERIMENTAL 
Apparatus and Techniques 
Unless otherwise stated, all concentrations and evaporations were 
performed using a Rineo rotating evaporator at temperatures below 50° 
and at water aspirator vacuum. Anhydrous magnesium sulfate (Mallinckrodt 
AR 6070) was used in drying chloroform extracts. Anhydrous methanol was 
prepared as described elsewhere (31)• Redistilled benzene was dried us­
ing sodium ribbon. Anhydrous ether (Fisher Scientific Company, Reagent 
Grade E - I38 ) was further dried using sodium ribbon. Petroleum ether 
Ob.p . 30-60°) was redistilled, as was acetone, before use. Ethyl acetate 
was dried by distillation from powdered phosphorous pentoxide. Pyridine 
was purified by distillation from potassium! hydroxide pellets until the 
distillate did not become pale yellow on storage over potassium hydro­
xide pellets. Acetic anhydride was redistilled, as was acetic acid. 
Tergitol anionic 7 (sodium heptadecyl sulfate) was purchased from Union 
Carbide. 
Streptomycin and dihydrostreptomycin sulfate used in this work 
were provided by Merck Sharp and Dohme Company, and Charles Pfizer and 
Company. 
Melting points were observed using a Kofler hot stage melting 
point apparatus and are corrected, unless otherwise stated. Micro­
analyses were performed by Bernhardt Laboratories, Mulheim, West Germany. 
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A Perkin-Elmer Model 137 Infracord recording spectrophotometer was used 
for all infrared spectra„ The pH values were monitored using a Leeds 
and Northup pH meter, Model 7^-01. A Bellingham and Stanley polarimeter 
(Model 397619) equipped with a General Electric Sodium Lab-Arc lamp as 
a source of the sodium D-line was used for the determination of optical 
rotations. 
Nuclear magnetic resonance (n.m.r.) spectra were determined 
using a Varian Model A-60D spectrometer. The; magnet temperature was 
essentially constant at some value around 30° during the determination 
of a given spectrum. Unless otherwise indicated, the chemical shift 
values are reported in T units (T = 10-6). Tetramethyl silane (TMS) 
and 2,2-dimethyl-2-silapentane-5-sulfonate (DSS) were used as internal 
standards for organic solvents and water, respectively. The area of a 
peak was measured using a Gelman Instrument Company (Model 39231) plani-
meter. 
Thin-layer chromatography was performed as described elsewhere ( 7 ) . 
Silicic acid column chromatography was performed by making a slurry of 
the specified amount of silicic acid (100 mesh, Mallinckrodt AR-28^7) 
with chloroform. The slurry was poured in a suitable column fitted 
with a coarse sintered glass disc at the lower end. The slurry was 
allowed to settle, excess chloroform was drained, and the column was 
vibrated by tapping with a rubber stopper until the adsorbant was firm. 
The techniques employed for gas-liquid chromatography have been 
described elsewhere ( 7 ) . A Glowall Corporation Chromalab (Model A-110) 
instrument equipped with a Minneapolis Honeywell continuous recorder 
was employed. The dimensions of the column and the nature of the packing 
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material are described in the text. 
Paper chromatography was performed as described elsewhere ( 3 2 ) . 
The ion-exchange resins used were regenerated as by the method of 
Hayes ( 3 2 ) . The volume of the resin was determined by allowing the resin 
to settle to a constant volume in a graduated cylinder. Amberlite anion 
exchange resin k-5 in the chloride phase [iRA k-5 (Cl~)] was used after 
washing to a pH of 3-3=5. 
The Sephadex used in this work was purchased from Pharmacia Fine 
Chemicals, Inc.; the material was soaked in 0 .01 N formic acid overnight 
before packing a column. An automatic fraction collector (GM Instrument 
Company) was used in all column chromatographic separations. 
Conversion of Streptomycin Sulfate to Streptomycin Trihydrochloride 
A solution of LH.6 g (0 .02 mole) of streptomycin sulfate (Charles 
Pfizer and Company) in 60 ml of distilled water was mixed with a solution 
of 6.61+0 g of barium chloride (0.03 mole) in a 500-ml beaker. The pre­
cipitate formed was filtered using a Celite mat in a sintered glass 
funnel. A sample of the filtrate yielded no precipitate with a few 
drops of the barium chloride solution. The filtrate was concentrated 
under vacuum and then dried overnight in vacuo using a vacuum pump at 
room temperature. The dried residue, light pink in color, was dissolved 
in 150 ml of anhydrous methanol. About 200 ml of redistilled acetone 
was added to the solution; the resulting precipitate was filtered using 
a medium sintered glass funnel. The residue was dried in vacuo and re-
precipitated from its methanol solution using acetone. 
The weight of dried hydroscopic residue was 10.607 g (79 percent). 
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Conversion of Streptomycin Trihydrochloride to Streptomycin Tergitate 
The crystalline streptomycin tergitate was prepared according to 
the method of Heuser, et al. (22) as modified by Young (26). 
To a solution of 10 g of streptomycin trihydrochloride in 3.3 1 
of distilled water (concentration of streptomycinf 3000 (i.g/ml) was 
gradually added 57 ml of Tergitol-7 anionic over a period of 20 minutes. 
During the addition the mixture was stirred using a magnetic stirrer, 
and the pH was maintained between 7.0 and 7.5 by periodic addition of 1 
N-hydrochloric acid. The white precipitate that formed was allowed to 
settle, and the suspension was kept in a refrigerator for five days. 
After this period, most of the slightly turbid supernatant liquid was 
decanted. The residue was filtered using hardened filter paper and was 
allowed to dry in air. The white residue was transferred to a flask and 
lyophilized. The dried residue weighed 18.986 g (56 percent). 
An amount of 2.017 g of the crude tergitate was dissolved in 10 ml 
of anhydrous methanol. The insoluble material was filtered. To the 
filtrate, 0.02 ml of 1 I sulfuric acid was added. The solution was made 
slightly cloudy by the addition of about 1 milliliter of water. After 
cooling.overnight, white needle shaped crystals were obtained that 
melted at 142-143° and had an optical rotation of - 2 3 .4 Q (c_ 1.0,. methanol) 
[lit (22) mp lkl-lkZ°, [a] 2 5 -25° (c 1, methanol)]. 
Preparation of B-Streptomycin Trihydrochloride 
This salt was prepared according to the method of Heuser (22). A 
solution of 20 g of crude, aged, and dried streptomycin tergitate was 
mixed with 100 ml of anhydrous methanol. The insoluble material was 
filtered. To the filtrate, 70 ml of 10 percent calcium chloride in 
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methanol "(containing 0.7 ml of concentrated hydrochloric acid) was 
added. White crystals began to appear at once. After keeping the mix­
ture in the refrigerator for 16 hours, the crystals were filtered and 
dried under vacuum; the yield was 3-305 g (33 percent). The crystals 
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were recrystallized from anhydrous methano 1 and had [a]J - 89 .6° (c 1 , 
water), [lit. (22) - 8 6 . 1 (c 1 .0 , water)]. The final weight of the 
crystals after drying was 2.I+766 g. 
Studies on the Quantity of p-Streptomycin Trihydrochloride 
Recovered by Aging of Streptomycin Tergitate 
The streptomycin tergitate, prepared as described earlier, was 
aged at 5° for periods of one to seven days. The lyophilized crude 
streptomycin tergitate was converted to p-streptomycin trihydrochloride 
by metathesis with calcium chloride solution as described earlier. The 
percentage yield of p-streptomycin trihydrochloride based on the start­
ing amount of a-streptomycin trihydrochloride is tabulated in Table 2 . 
Table 2 . Effect of Aging Upon Yields of p-Streptomycin 
Duration of Aging 
One day 
Four days 
Five days 
Six days 
Seven days 
Percentage Yield of 
p-Streptomycin Trihydrochloride 
28 
35.5 
k2 
kk 
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Preparation of [3-Streptomycin Trihydrobromide 
This salt was prepared as described by Heuser ( 2 2 ) . A 2.3170 g 
sample of crystalline g-streptomycin tergitate was mixed with 12 ml of 
anhydrous methanol. The suspended material was filtered. The filtrate 
was mixed with 12 ml of a freshly prepared 10 percent solution of an­
hydrous calcium bromide in methanol. On standing in the refrigerator 
overnight, white crystals separated. These were filtered and dried; 
the yield was 0.350 g (26 percent). The material had no sharp melting 
O O _ 
point and had [a] -69 (c 1 .2 , water) (lit. - 7 2 . 1 ° ) . 
Attempted Preparation of g-Streptomycin Trihydroiodide 
Using Calcium Iodide 
The method followed for this preparation was based on the proce­
dure that had been used (22) for other trihalides. 
The calcium iodide required for this preparation was available 
commercially only as the polyhydrate (City Chemical Corporation, New 
York, N. Y.; U.B. 821) . It was dried by boiling a solution of 12.132 g 
of calcium iodide hydrate and 12 g of 2,2-dimethoxypropane under reflux 
for l 6 hours. The solvent and water were evaporated and the resulting 
solid (9.576 g) was dissolved in methanol to make a 10 percent solution. 
Twenty grams of crude aged streptomycin tergitate was mixed with 
100 ml of methanol. The suspended material was filtered. The filtrate 
was mixed with 1^5 ml of a 10 percent solution of anhydrous calcium 
iodide in methanol. On standing at 5° for 16 hours, no crystals appeared. 
On prolonged storage for seven days only a slight cloudiness resulted. 
Other preparations were attempted using 12 percent and 15 percent 
solutions of calcium iodide in methanol, but no crystals appeared. Even 
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when crystalline B-streptomycin tergitate was used, no crystals resulted. 
Attempted Preparation of B-Streptomycin Trihydroiodide 
Using Sodium Iodide 
• A solution of 295 mg (O.36 millimole) of 8-streptomycin tergitate 
in 1.5 ml of methanol was mixed with a solution of l6h mg of sodium 
iodide in 1 ml of acetone. The solution was stored at 5° for four months. 
No precipitate or crystals appeared. 
Reduction of p-Streptomycin Trihydrochloride 
Fried and Wintersteiner's method (5 ) for reducing a-streptomycin 
was used for this reduction except that 5 percent platinum on carbon was 
the catalyst instead of platinum oxide. 
In a 250-ml hydrogenation bottle, 70 ml of redistilled acetic 
acid (Fisher Reagent) was employed to suspend 5.2 g of 5 percent platinum 
on carbon (Englehard Industries, Newark, New Jersey, Lot 563*0. The 
apparatus was flushed five times with nitrogen and five times with 
hydrogen and left in an atmosphere of hydrogen for 16 hours for equili­
bration. 
Then, 2.^77 g (3 .6 millimoles) of p-streptomycin trihydrochloride 
dissolved in 20-ml of water was added to the hydrogenation bottle. The 
uptake of hydrogen after 16 hours was 79 ml (3 .6 millimoles). The 
catalyst was filtered using a Gelite mat,and the filtrate was lyophil-
lized. The weight of the residue was 2 .1^2 g after drying overnight 
under vacuum. The melting point was 239-24l° and the preparation had 
[<*] 2 2 = -77° (c 1.0, water). 
21 
Conversion of g-Dihydrostreptomycin Sulfate 
to the g-Naphthalenesulfonate Salt 
This salt was made by a modified procedure (43) of Regna and 
Carboni ( 3 3 ) . 
In a 50-ml Erlenmeyer flask, 2 . 5 8 l g ' (3 .5 millimoles) of dihy-
drostreptomycin sulfate was dissolved in 10 ml of distilled water. In 
another flask, 2.523 g of sodium 8-napthalenesulfonate (Eastman, white 
label) was dissolved in 11 ml of warm water. The two solutions were 
mixed and kept at room temperature overnight. Small white crystals 
appeared in the flask. These were filtered, dried, and recrystallized 
from hot water. The yield was O .873 g, mp 203-204° (corr.) [lit. 184-
1 8 6 ° ] , [ a ] 2 1 = -57° (c, 1 .0 , water) [lit. - 5 2 . 1 ( 3 3 ) ] . 
Conversion of C r u d e g-Dihydrostreptomycin Trihydrochloride 
to the g-Naphthalenesulfonate Salt 
Beta-Dihydrostreptomycin trihydrochloride (O .256 g; 0 .34 milli-
mole) was dissolved in 1 milliliter of water and mixed with a solution of 
0.260 g of sodium 8-naphthalenesulfonate (Eastman, white label) in 1.3 
ml of water. On standing for 16 hours at room temperature, white 
crystals appeared. These were, filtered, dried, and recrystallized 
twice from not water. The yield was 21 mg, mp 175.8-176.8° (corr.). 
Preparation of q-Dihydrostreptpmycin Trihelianthate Salt 
This preparation was attempted using the method of Fried and 
Wintersteiner ( 5 ) . A solution of 0.156 g (0 .22 millimole) of a-dihydro-
streptomycin trihydrochloride in 2.2 ml of water was mixed with a solu­
tion of 0.264 g of methyl orange in 5 ml of 50 percent methanol. Crystals 
began to form immediately. After standing 2 hours at room temperature, 
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the crystals were filtered and recrystallized from 50 percent methanol. 
The yield was 270 mg. No sharp melting point was observed, although 
o ' the crystals appeared to start decomposing at 220 . 
Preparation of the Trihelinthate Salt of Crude g-Dihydrostreptomycin 
This salt was also prepared by the same procedure as the one for 
a-dihydrostreptomycin. A solution of 0.1^2 g (0 .20 millimole) of crude 
g-dihydrostreptomycin trihydrochloride in 2 ml of water was mixed with 
a solution of 0 . 2 6 l g of methyl orange in 5 ml of 50 percent methanol. 
On standing, crystals appeared which were collected by filtration, re-
crystallized from dilute methanol, and dried. The yield was 0.246 g; 
mp 217-219° (dec). 
Orange II Salts of g- and Crude g-Dihydrostreptomycins 
A sample of 95 mg (0 .12 millimole) of a-dihydrostreptomycin tri­
hydrochloride was dissolved in 1 milliliter of water. Another solution 
of 87 mg (O.U millimole) of g-dihydrostreptomycin trihydrochloride in 
1 milliliter of water was also prepared. 
A solution of 0.9001 g of Orange II (Fisher Scientific Company, 
0-266, 721371) was prepared in 10 ml of water and 1 milliliter of abso­
lute ethanol. Two milliliters of the Orange II solution was added to 
each of the dihydrostreptomycin solutions. On keeping for 16 hours at 
5 ° , scarlet crystals appeared in both the mixtures. These crystals were 
filtered, recrystallized from hot water, and dried. 
The salt form a-dihydrostreptomycin trihydrochloride weighed 110 
mg and had a mp 222-223° (dec). The salt from crude g-dihydrostreptomy-
cin weighed 113 mg and had a sharp mp of 216-217°. 
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Attempted Purification of the Crude g-Dihydrostreptomycin 
A solution of 3.61+91 g (5 .3 millimoles') of g-dihydrostreptomycin 
trihydrochloride preparation in 50 ml of water was mixed with a solution 
of 6.2538 g of methyl orange in 250 ml of 50 percent methanol. 
Crystals began to appear immediately. After standing 2 hours 
these crystals were filtered and recrystallized twice from 60 percent 
methanol. The final weight of the trihelinthate salt was 5-039 g. 
In a 200-ml Erlenmeyer flask, 2.1+36 g ( 1 . 7 millimoles) of the 
trihelinthate was dissolved in 100 ml of 50 percent methanol and stirred 
for 6 hours with 50 ml of ion exchange resin IRC 1+5 (0H~ phase). The 
resin was filtered and the filtrate was. passed over a column of 50 ml 
of ion exchange resin IRC 1+5 (Cl~ phase; washed to pH 3 . 0 - 3 - 5 ) . The 
column was washed with 500 ml of water. After concentration and lyo-
philization, 0.81+7 of g-dihydrostreptomycin trihydrochloride was recovered. 
N-Carbobenzoxylation of Crude g-Dihydrostreptomycin Trihydrochloride 
A modified version of the method described by Polglase (35) was 
used for the N-carbobenzoxylation at the methylamino nitrogen. 
In a typical preparation, 0.610 g ( 0 . 9 millimole) of the g-dihy­
drostreptomycin trihydrochloride preparation was dissolved in 10 ml of 
water. The pH of the solution was adjusted to 8.5 and maintained between 
pH 7.0 and 9.5 hy occasional addition of ion-exchange resin (Amberlite 
IRA 1+00 (OH" phase) washed to pH 9 . 5 - 1 0 . 0 . 
The solution was agitated using a magnetic stirrer, and 790 mg 
(1+.5 millimoles) of carbobenzoxy chloride was added dropwise over a 
period of about 20 minutes. Stirring was continued for a period of 
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Figure 1 . N.m.r. Spectrum of the N-Carbobenzoxylated Deriva­
tive of Crude B-Dihydrostreptomycin 
ro 
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about 2 hours during which the pH was maintained between the above-
mentioned limits. After this period, the resin was filtered, and the 
filtrate was washed with three 50-ml portions of ether. The aqueous 
portion was concentrated to remove dissolved ether and was passed.over 
a column of 50 ml of ion-exchange resin IRC-U5 (Cl~ phase). The column 
was further eluted with 100 ml of distilled water. The eluants were 
pooled and lyophilized. The final weight of the recovered carbobenzo-
xylated preparation was O.khO g. 
The n.m.r. spectrum of this preparation in deuterium oxide re­
vealed the following pertinent peaks: (i) a singlet at 2 .7 T correspond­
ing to C-phenyl protons; (ii) a complex multiple between 5.0 and 7.0 T , 
corresponding to various ring protons; (iii) two singlets at 7.15 and 7.25 
T corresponding to the N-CH^ protons; (iv) a doublet at 8 .9 T , correspond­
ing to protons. 
The peaks at (i) and (iv) were expanded at 50 cps and gave a 
respective area of 168 squares and 329 squares. * 
In subsequent experiments, unless otherwise specified, the crude 
g-dihydrostreptomycin used was found to contain at least 70 percent g-
dihydrostreptomycin by n.m.r. analysis; the remainder was a-dihydro-
streptomycin. 
A solution of"150 mg (0.24 millimole) of the "purified" g-dihydro­
streptomycin trihydrochloride in 10 ml of water was treated with 5 ml of 
carbobenzoxy chloride in the presence of ion exchange resin IR kOO (OH 
phase) to maintain the pH between 8 . 5 - 9 . 0 . The workup was identical to 
that described previously. 
The final n.m.r. analysis revealed that 23 percent of N-carbenzoxy-
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a-dihydrostreptomycin was present. 
Methanolysis of g-Dihydrostreptomycin Trihydrochloride 
The procedure adopted was the same as described elsewhere ( 5 ) . 
A sample (8.407 g, 12. 2 millimoles) of a-dihydrostreptomycin 
trihydrochloride was dried over phosphorus; pentoxide at 60° under high 
vacuum for a period of two hours. It was dissolved in 173 ml of 1.0 N 
hydrogen chloride in dry methanol and allowed to stand at room tempera­
ture for 48 hours. 
At the end of this period, 370 ml of dry ether was added to the 
solution with constant stirring. The white precipitate of streptidine 
hydrochloride was filtered and dried under vacuum. The weight of the 
streptidine was 4.697 g (98 percent). The filtrate was concentrated to 
25 ml; the cloudy solution was centrifuged for 20 minutes. The super­
natant solution was poured into 250 ml of dry ether. It was kept at 5° 
for l 4 hours. The oily layer that resulted was separated from the 
supernatant solution by decantation and was washed with dry ether (3 x 
50 ml). The oily layer was poured into a crystallizing dish and was 
dried under vacuum over potassium hydroxide and phosphorus pentoxide 
for l 6 hours. The white solid methyl dihydrostreptobiosamine weighed 
3 . 8 6 l g (72 percent), started decomposing at 182° [lit, mp 182-183° 
(dec)], and had [<x]^2 = -130° (c 1 .20, methanol, (lit. -135°) ( 5 ) . 
Methanolysis of (3-Dihydrostreptomycin Trihydrochloride 
A sample of dried crude (3-dihydrostreptomycin trihydrochloride 
(0 .79^ g, 1.17 millimoles) in 17 ml of 1 N hydrogen chloride in dry 
methanol was kept at room temperature for 48 hours. At the end of this 
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period, 36 ml of dry ether was poured into this solution. The white 
precipitate that resulted was filtered, dried, and weighed, 0.410 g 
(99 percent). The precipitate was identified as streptidine dihydro-
chloride. Identification was established by preparing a solution of 
98 mg of this streptidine dihydrochloride in 2 ml of water and mixing 
this with a solution of 50 mg of anhydrous sodium sulfate in 3 nil of 
water. On standing in the refrigerator, white crystals appeared. These 
crystals were the known streptidine sulfate. 
The ether-methanol filtrate from the collection of streptidine 
dihydrochloride was concentrated in vacuo to about 3 milliliters. The 
mixture was centrifuged to remove suspended material and then concen­
trated and dried in vacuo over potassium hydroxide and calcium chloride. 
A highly hygroscopic, white glassy solid formed which was further dried 
at 60° over phosphorus pentoxide for 1 hour in vacuo. It had no sharp 
melting point and started decomposing at 185°; it weighed 365 mg and had 
[alp = - 99 .2° (c_ 1 .29, methanol)([lit, for methyl a-dihydrostreptobios-
aminide, -135° (c 1 .15, methanol). 
Gas-Liquid Chromatographic Analysis of Crude 
Methyl @-Dihydrostreptobiosaminide 
The analysis was carried out on the 0-silyl derivative of the 
crude methyl 0-dihydrostreptobiosaminide prepared using the method of 
Sweeley and co-workers ( 3 7 ) . In a glass vial with a plastic cap 10 mg 
of the methyl g-dihydrostreptobiosaminide prepared above was dissolved 
in 1 milliliter* of dry pyridine. To this solution, 0.2 ml of hexamethyl-
disilazane and 0 . 1 ml of trimethylchlorosilane were added. Dense white 
fumes appeared. The vial was capped and shaken well for 30 seconds. A 
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white precipitate appeared. The supernatant liquid was analyzed on a 
gas chromatographic apparatus using a 6-foot column of SE-30 at 200°, 
detector at 1^5° and sampler at 250°. Helium was used as the carrier 
gas at the rate of 25 ml per minute. Two major peaks were observed 
that had retention times of 11 minutes and 33 minutes; the areas were 
• in the ratio of 1:3, respectively. The O-silylderivative of methyl 
a-dihychostreptobiosaminide gave only one peak (ll minutes). 
Reduction of B-Streptomycin Trihydrochloride 
Using a Variety of Catalysts 
The reduction of B-streptomycin trihydrochloride was carried out 
on a small scale (ca_. 0.5 to 1.0 millimole quantity), using rhodium 
(5 percent on carbon), palladium (5 percent on carbon), platinum oxide, 
and platinum (5 percent on carbon). In each case the workup was the 
same as described previously. The lyophilized B-dihydrostreptomycin 
trihydrochloride was found to give a negative Fehling test and a nega­
tive maltol test. Each was subjected to carbobenzoxylation according 
to the procedure described previously. The resulting products gave the 
results by an n.m.r. analyses shown in Table 3. 
Mercaptolysis of Crude B-Dihydrostreptomycin Trihydrochloride 
The procedure followed has been described previously by Kuehl and 
co-workers ( 3 8 ) . 
A sample of dried (under vacuum, at room temperature) crude B -
dihydrostreptomycin trihydrochloride (1 .760 g; 2 .5 millimoles) was 
stirred with 18 ml of ethanethiol in a three-necked round bottomed flask 
fitted with a mechanical stirrer. The flask was kept in an ice bath and 
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Table 3. Effect of Catalysts on the a-Dihydrostreptomycin 
- Content of Reduced B-Streptomycin 
Catalyst 
Reaction 
Period 
Percentage of a-Dihydro-
streptomycin from Carbo-
benzoxylation 
Palladium on 
charcoal 
14-16 hours 100 
Rhodium on 
charcoal 
l 4 - l 6 hours 100 
Platinum oxide l 4 - l 6 hours 30 
Platinum on 
charcoal 
7 days 30 
Platinum on 
charcoal 
5 days 21 
hydrogen chloride bubbled through the contents for 1 hour to insure 
saturation. The mixture was then stirred for 24 hours at room tempera­
ture. 
The solvent was evaporated under vacuum with constant stirring 
to avoid any bumping. The glassy, hygroscopic pale yellow solid was 
dissolved in about 3 ml of methanol; 50 ml of 2-propanol was added to 
precipitate the streptidine hydrochloride which weighed 0.865 g (99 
percent). The filtrate, after removal of the streptidine hydrochloride, 
was concentrated in vacuo; the resulting brownish powder weighed 0.797 g. 
Attempts to crystallize this material in a variety of solvents did not 
succeed. Chromatography over a column of acid washed alumina (l cm x 
55 cm) using 50 percent methanol in benzene as the solvent gave no 
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fractions that could be crystallized; 
Using thin layer chromatography and employing alumina plates, the 
values listed in Table k were obtained. R^ , values obtained for ot-
dihydrostreptobiosaminide thioacetal (prepared by Torline by the same 
procedure) (36) are also listed. 
Table k. Thin-Layer Chromatographic Analysis of 
a- and p-Dihydrostreptobiosaminide Thioacetal 
4n-
Values 
cv-Dihydrostrepto- 8-Dihydrostrepto-
biosaminide biosaminide 
Solvent System Thioacetal Thioacetal (Crude) 
l-Propanol:Acetic Acid: 0.5 0.5 
Water ( 2 :1 :1 ) 
l-Butanol:Acetic Acid: 0 .6 0.8 
Water ( 2 :1 :1 ) 
The spots were visualized using iodine vapors. 
Acetylation of Crude [3-Dihydrostreptomycin Trihydrochloride 
A modified procedure of Comrie and co-workers was used (39) -
A sample (0.907 g, 1.3 millimoles) of crude |3-dihydrostreptomycin 
trihydrochloride was stirred with 16 ml of redistilled acetic anhydride. 
After the addition of 1.120 g of sodium acetate an additional 16 ml of 
acetic anhydride was added and the reaction mixture was kept at room 
temperature for 48 hours. It was next stirred-at 50° for 5 hours; there­
after the solvents were removed under vacuum and the semisolid residue 
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was mixed with 50 ml.of dry benzene to remove insoluble sodium acetate 
by filtration. The benzene solution, when slowly mixed with 200 ml of 
petroleum ether with constant stirring, gave a light-brown precipitate, 
which was washed with petroleum ether (3 x 25 ml), and weighed 1.036 g. 
The i.r. spectrum showed peaks at X 5.65 and 6.15n, among 
max 
others. 
This preparation^ along with authentic peracetyl-a-dihydrostrepto­
mycin (prepared elsewhere (36)) was subjected to paper chromatographic 
analysis. The results are given in Table 5. 
Table 5. Paper Chromatographic Analysis of Peracetyl Crude-
8- and a-Dihydrostreptomycin 
Rp Values 
Peracetyl Crude-8- Peracetyl-Q'-Dihydro-
Solvent System Dihydrostreptomycin streptomycin 
5 Percent Methanol 0.0, 0.22 0.15, 0.23 
in Benzene 
5 Percent Methanol 0.0, 0.3, 0.5 0.0, 0.3, O.k, 0.55 
in Chloroform 
9 Percent Ethylacetate 0.0 0.0 
in Benzene 
Acetone 0.0, ,0.15, 0.2 0.0,0.15 
Whatman No. 1 filter paper was used in this analysis. The spots 
were identified by spraying with Weber reagent. 
Attempted Separation of Crude g-Dihydrostreptomycin 
Trihydrochloride on a Sephadex G-15 Column 
A column with an inner diameter of 1.9 cm was packed to a height 
of 475 cm with a slurry of Sephadex G-15 that had been, soaked for 16 
hours in 0 .01 M formic acid. A 5 ml solution containing I.632 g (2 .5 
millimoles) of crude g-dihydrostreptomycin trihydrochloride was care­
fully poured onto the top of the column and was washed on with 0 .01 M 
formic acid solution. 
Each fraction(l5 ml) was evaporated to dryness and analyzed by 
ascending paper chromatography using Whatman Wo. 1 paper and t-butyl 
alcohol:acetic acid:water ( 2 :1 :1 ) as the solvents. The major fraction 
and several tailing fractions gave two spots each with 0.19 and O .63. 
The spots were visualized by spraying with Weber reagent. On identical 
analysis, a-dihydrostreptomycin trihydrochloride gave only one spot of 
Rp 0 .17 . 
Chromatography of Crude g-Dihydrostreptomycin 
Trihydrochloride on a Cellulose Column 
This chromatographic analysis was carried out on the basis of 
the procedure described elsewhere (^0) . 
To 50 g of powdered cellulose was added 100 ml of the solvent 
mixture t-butyl alcohol: acetic acid: water ( 2 : 1 : 1 ) , and the slurry 
was filtered using hardened filter paper. The cellulose powder was 
transferred to a large evaporating dish-to dry in air for nine days. 
The powder was occasionally stirred during this period. A column (1 .8 
cm in internal diameter and 50 cm long) was dry-packed using a heavy 
glass rod with one end flattened to tamp down each of the 80 portions 
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of the cellulose. 
A solution of 1.322 g (1 .9 millimoles) of the preparation in 1 
milliliter of water was slurried with about 3 g of cellulose. The mix­
ture was thoroughly mixed and dried under vacuum over potassium hydro­
xide. The dried powder was ground, subjected to the same procedure two 
more times and dry-packed on the top of the column. Two milliliters more 
of cellulose were packed on the top. The eluting solvent used was t-
butyl alcohol:acetic acidrwater ( 2 :1 :1 ) and the column was run under a 
pressure of 3 psi. Fractions measuring 25 ml were collected and lyophil-
ized. 
Fractions 1 and 2 gave two spots with R^ values of 0.3 and 0 .83; 
the latter one was faint. The other fractions gave only one spot at 
values between 0.25 and 0 . 3 . When these fractions were subjected to 
carbobenzoxylation, the usual partial N-carbobenzoxylation was observed 
showing that about 30 percent or-dihydrostreptomycin was present. The 
total weight recovery from this column was l.k^6 g (110 percent). 
Thin-Layer Chromatographic Analysis of the Compound 
Resulting from N-Carbobenzoxylation of Crude B -
D ihydro strep to myc in 
The crude B-dihydrostreptomycin trihydrochloride that had been 
subjected to N-carbobenzoxylation was analyzed both on silicic acid 
HF 254 and on normal cellulose plates along with a sample of the crude 
B-dihydrostreptomycin. The spots were visualized both by ultraviolet 
light and Weber reagent. The results are shown in Table 6. 
3^ 
Table 6. Thin-Layer Chromatographic Analysis of Crude g-
Dihydrostreptomycin and the Compound"Resulting' 
from Its N-Carbobenzoxylation 
2 * . 
Values 
Solvent System N-Cbz of (3-DHS g-DHS 
(Adsorbant: Silicic Acid HF 254 Plates) 
Ethanol:Acetic Acid:Water 
( 3 :1 :1 ) 
Pyridine:Water 
(1:1) 
t-Butyl Alcohol :Acetic 
Acid:Water 
( 2 :1 :1 ) 
0.13 M Formic Acid 
0.3 
O .67 
0.24 and 
0.53 (faint) 
0.75 
0.3 
0.66 
0 .21 
0.77 
Ethanol:Acetic Acid:Water 
( 3 :1 :1 ) 
t-Butyl Alcohol:Acetic 
Acid:Water 
( 2 :1 :1 ) 
(Adsorbant: Normal Cellulose) 
0.73 
0 . 8 l and 
0.09 (faint) 
0.73 
0.73 and 
0.09 
0.13 M Formic Acid 0.9 0.9 
N-Cbz of g-DHS signifies the product resulting from the N-carbo­
benzoxy la tion of crude g-dihydrostreptomycin. 
g-DHS signifies crude preparation.of g-dihydrostreptomycin. 
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Thin-Layer Chromatographic Analyses, of g-Streptomycin 
Trihydrochloride and Related Streptomycin Derivatives 
on Silicic Acid Plates 
This analysis was carried out using TLC plates made of silicic 
acid HF 254 by a previously described procedure (lO). The solvents 
employed were 1 percent ammonium formate, 4 percent ammonium formate, 
and 1 percent sodium acetate. The developing time was about 30 minutes 
and the spots were visualized using ultraviolet light and by Weber 
reagent spray. The results are given in Table 7. 
Table 1. Thin-Layer Chromatographic Analysis of g-Strepto-
mycin and Other Streptomycin Derivatives 
Compound 
4?-
Values 
1 % Ammonium 4 % Ammonium 1 $ Sodium 
Formate Formate Acetate 
Streptidine 0.80 
Hydrochloride 
a-Streptomycin Tri- 0.60 
hydrochloride 
g-Streptomycin Tri- 0.60 
hydrochloride 
a-Dihydrostreptomycin 0.52 
Trihydrochloride 
Crude g-Dihydrostreptomycin O.56 
Trihydrochloride 
N-Cbz of Crude g-Dihydro- 0.76 
streptomycin 
N-Cbz-a-Dihydrostrepto- 0.52 
mycin Hydrochloride 
0.92 
0.80 
0.90 
0.78 
0.80 
0.88 
0.80 
0 .71 
0.43 
0.43 and 
0 .71 (faint) 
0.35 
0.43 
0 .6 
0.36 
* Signifies the product resulting from the N-carbobenzoxylation of 
crude g-dihydrostreptomycin. 
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Thin^Layer Chromatographic Analyses of g-Streptomycin and 
Related Compounds Using Microcrystalline Cellulose 1 
Microcrystalline cellulose (purchased from Applied Science 
Laboratories) was used to prepare the plates. A slurry of 100 g of 
this cellulose with 430 ml of water was mixed in a Waring blender for 
30-40 seconds and spread on clean glass plates to a thickness of 0.25 
mm. The plates were dried at room temperature for 4 hours and stored 
over indicating silica gel desiccant at room temperature. The solvent 
system used was t-butyl alcohol: acetic acid: water (4 :1 :5 ) . The 
spots were visualized by spraying with Weber reagent. The R^ values 
obtained are shown in Table 8. 
Table 8. Thin-Layer Chromatographic Analyses of B-
Streptomycin and Related Compounds on Micro-
crystalline Cellulose Plates 
Solvent: t-butyl alcohol:acetic acidrwater (4:1:5) 
Compound Rp Value 
Streptidine Hydrochloride 0 .63 
or-Streptomycin Trihydrochloride O.58 
8-Streptomycin Trihydrochloride O .58 
ar-Dihydrostreptomycin Trihydrochloride O.63 
Crude 8-Dihydrostreptomycin Trihydrochloride O.63 
N-Cbz of B-Dihydrostreptomycin Trihydrochloride 0.58 and 0.60 
'N-Cbz-or-Dihydrostreptomycin Dihydrochloride 0 .73 
Signifies the product resulting from the N-carbobenzoxylation of 
crude 8-dihydrostreptomycin. 
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In the solvent system l-butanol:acetic acid:water (4:1:5), the 
following Rp values obtained are shown in Table 9« 
Table 9- Thin-Layer Chromatographic Analysis of Crude 8-
Dihydrostreptomycin and Related Compounds on 
Microcrystalline Cellulose Plates 
Solvent: l-butanol:acetic acid:water (4:1:5) 
Compound Rp Value 
Crude 8-Dihydrostreptomycin 0.46 
Trihydrochloride 
N-Cbz of 8-Lihydrostreptomycin 0.48, 0.67, and 0.41 (faint) 
Chloride* 
a-Dihydrostreptomycin 0.55 
T ri hydro chlo r i de 
N-Cbs-a-DHS 0 .61 
Signifies the compound resulting from the N-carbobenzoxylation 
of crude 8_(iihydrostreptomycin. 
Signifies N-carbobenzoxy-a-dihydrostreptomycin 
Attempted Separation of the Compound Resulting from the 
N-Carbobenzoxylation of Crude g-Dihydrostreptomycin 
Using Microcrystalline Cellulose Plates 
The cellulose plates were made from a slurry of microcrystalline 
cellulose and water as described above, except that the cellulose layer 
was 1 millimeter thick. 
A solution of 109 mg of the N-carbobenzoxy product of crude 8-
dihydrostreptomycin in 2 ml of 50 percent ethanol was spotted on the 
plates (two 10 cm x 20 cm and one 20 cm x 20 cm). The eluting solvent 
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mixture consisted of l-butanol:acetic acid:water ( 4 : 1 : 5 ) . • The develop­
ing time was k hours. The plates were then air-dried and-a small 
oblong area was sprayed with Weber reagent. The spots observed were 
diffused and overlapped with each other; thus, no separation for 
practical purposes was realized. 
Paper Chromatography of Crude B-Bihydrostreptomycin 
Trihydrochloride and Related Compounds 
This analysis was performed in accordance with the procedure 
described elsewhere (hi) and its modification. 
A borate buffer was prepared by dissolving 0.0621 g of boric 
acid and 0 .021 g of borax in water and making up the solution to 100 ml. 
This buffer was used to make a 0.5 percent solution of sodium chloride. 
In 100 ml of n-pentyl alcohol (Matheson-Coleman Bell 7232, P x k) was 
added 1 milliliter of di-2-ethylhexyl phosphate (Stauffer Chemical 
Company). Equal volumes (100 ml each) of the sodium chloride solution 
and n-pentyl alcohol were mixed and the pH of the mixture was adjusted 
to 8 .0 while stirring, with a few drops of 10 percent sodium hydroxide. 
Stirring was continued for another 30 minutes. After this period the 
mixture was allowed to settle in a separatory funnel and the two phases 
were separated. A suitably sized sheet of Whatman No. 20 chromatography 
paper was dipped in lower or aqueous phase, avoiding any contact with 
fingers. The paper was blotted between two sheets of Whatman No. 20 
paper and the aqueous solutions of the samples referred to in Table 10 
were applied onto the blotted sheet in small quantities. The sheet was 
developed by the descending method using the upper or organic phase. 
The developing time was about 8 hours. The sheet was removed from the 
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Table 10. Results of Descending Paper Chromatography 
Using Whatman-No. 20 
Compound Rp Value 
Crude B-Dihydrostreptomycin 0.63 
T rihydro chlo ri de 
Compound Resulting from N- 0.72 and 
Carbobenzoxylation.of Crude 0 . 6 l (faint) 
B-Dihydrostreptomycin Tri­
hydrochloride 
<2-Dihydrostreptomycin O.58 (streak) 
Trihydrochloride 
Streptidine O.79 
tank, air-dried, and sprayed with alkaline #-naphthol-diacetyl color 
reagent (51). Brown-colored spots appeared that had values listed 
in Table 10. 
Chromatography of the Compound Resulting from N-Carbo­
benzoxylation of Crude B-Dihydrostreptomycin Using 
Sephadex G-15 
Sephadex G-15 was soaked in an excess of 0 .01 N formic acid for 
16 hours before packing the column. The l6-foot column (internal dia*. 
meter 1.9 cm) was slowly packed with the Sephadex slurry and allowed 
to settle for 16 hours. A solution.of 2.830 g of partially carbobenzo-
xylated B-dihydrostreptomycin in 5 ml of 0 .01 N formic acid was poured 
onto this column and the column was washed with the same solvent. Each 
fraction (10 ml) was tested with Weber reagent to detect any streptomy-. 
cin derivative. 
I 
Fraction No. 
Figure 2. Plot of Fraction Number Versus Weight for Ion-
Exchange Column Chromatography of Polybenzoyl 
Preparation Resulting from the N-Carbobenzoxylation 
of Crude p-Dihydrostreptomycin 
Ul 
Selected fractions were analyzed using microcrystalline cellulose 
plates in ^ t-butyl alcohol:acetic acidrwater (U:l:5). The results are 
shown in Table 1 1 . 
Table 1 1 . TLC Analyses of Samples from Sephadex Column 
Chromatography of N-Carbobenzoxylated Crude 
(3-Dihydro s tr ep tomyc in 
Fraction Number Value 
7U 0 . 6 1 , 0.85 
79 0 . 6 1 , 0.85 
8U 0 . 6 1 , O.85 
89 O .69 , 0 . 7 7 , 0.85 (faint) 
98 0.5U, O.69 
103 0.U6, 0.77 
107 0.U6, 0.77 
11U 0.U6, 0.73 
117 0.U6, 0 .73 , O.83 (faint) 
122 0.U6, 0 . 7 3 , 0.83 (faint) 
The n.m.r. spectra of random fractions revealed the presence of 
aromatic protons in all of them. 
k2 
Benzoylation of the Compound Resulting from the N-Carboben-
zoxylation of Crude B-Dihydrostreptomycin 
The procedure for the benzoylation of cv-dihydrostreptomycin has 
been described elsewhere (43). A modified version was used. 
To 0.910 g (l.l millimoles) of the N-carbobenzoxylated crude B-
dihydrostreptomycin was added 3 nil of anhydrous pyridine. The mixture 
was stirred at 0° for about 20 minutes and then 2.310 g ( l 6 . 5 millimoles) 
of benzoyl chloride was slowly added. Stirring was continued for an 
additional hour at ice bath temperature. Thereafter the slurry was 
stirred for 16 hours at room temperature, during which time it became 
brick-red in color. 
The mixture was diluted with 0.5 ml of water, and 75 ml of 
chloroform was added. The supernatant dark-colored solution was re­
moved and the chloroform extract was washed with saturated solution of 
sodium bicarbonate (3 x 20 ml). The pooled sodium bicarbonate solution 
was backwashed with chloroform. On concentrating the pooled dry chloro­
form solutions, a dark-colored semisolid having the odor of pyridine 
was obtained. Attempts to crystallize this material using chloroform/ 
petroleum ether gave only an oily precipitate. Other solvents (aceto­
nitrile, benz ene, ethanol, etc.) also failed to give any crystalline 
material. 
Ion Exchange Chromatography of the Polybenzoylated Prepara­
tion Resulting from the N-Carbobenzoxylation of Crude 
B-D ihydro s tr eptomyc in 
The polybenzoylated compound prepared above was dried in vacuo. 
A sample of 1.188 g was weighed out. 
IRC-50 (H+ phase) Ion-exchange resin was packed in a column 
h3 
(35 cm x 2.5 cm). The sample (1.188 g) was applied to the column using 
a small quantity of 6:1 acetone-water. The eluting solvent used was 
6:1 acetone:water followed hy 0.05 W-hydrochloric acid in the same sol­
vent mixture. The weight versus number of the fraction is given in 
Figure 3. 
The fractions eluted using the neutral solvent showed no sharp 
melting point and the n.m.r. spectrum indicated extensive decomposition. 
The material obtained from the acidic solvent was whitish, insoluble 
in acetone, soluble in water, and when heated, began to decompose at 
250°. 
Attempted Separation of Polybenzoyl Crude g-Dihydrostreptomycin 
on a Column of Ion-Exchange Resin Dowex 50 (H*) 
A sample of crude g-dihydrostreptomycin trihydrochloride (0.731 g, 
1 millimole) was stirred with ho ml of anhydrous pyridine at 0° for 1 hour. 
Thereafter, 2 ml (2.3^0 g, 16.5 millimoles) of benzoyl chloride was 
slowly added over a period.of 5 minutes. Stirring was continued for 
another hour at 0° for 18 hours at room temperature, when the solution 
became dark red in color. It was diluted with 30 ml of chloroform and 
the chloroform extract was washed with a saturated solution of sodium 
bicarbonate until effervescence ceased (3 x 30 ml required). The 
chloroform solution was concentrated to a syrup under vacuum and the 
-syrup was mixed with less than 1 milliliter of chloroform followed by 
a few drops of petroleum ether (bp 40-6o°). On cooling the turbid mix­
ture an oil separated. The supernatant solution was pipetted into 
another flask. The oily residue, after drying, showed the absence of 
any streptomycin derivative by n.m.r. analysis. 
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Fraction No. 
Plot of Fraction Number Versus Weight for Ion-Exchange 
Column Chromatography of Polybenzoyl Crude B-Dihydro-
s treptomycin 
h5 
The supernatant solution dried in vacuo. The residue was dis­
solved in a mixture of actone and water (6:l) and passed over a column 
of ion-exchange resin IRC 50 (H+ phase, 1.2 cm x 48 cm); a mixture of 
acetone and water (6 :1 ) followed by 0.05 N hydrochloric acid in the 
same solvent mixture were the eluting solvents. 
The graph (Figure 4 ) shows the relation between the weights 
and the fraction numbers. 
The n.m.r. spectrum of fraction number 5 indicated the absence 
of any spectromycin derivative. The semi-crystalline material obtained 
after the evaporation of the neutral solvent melted at 120-124° (corr). 
The residue obtained from the evaporation of fractions eluted with 
acidified solvent showed non-conclusive n.m.r. spectrum. 
The TLC analyses of random samples on silicic acid HF 254 using 
the solvents indicated are given in Table 12. 
Table 12. TLC Analyses of Samples from Ion-Exchange Resin 
Chromatography of Polybenzoyl Crude 3-Dihydrostreptomycin 
-*F- Value in 
Fraction Number Chloroform Acetone 
2 0 .63 , 0 .37 , 0.16 0 . 90 , 0.75 
0 .08 , and 0.00 and 0.00 
5 0.63 (faint), 0 .4 0 . 8 , 0.37 
(faint), 0 .16 , 0 .08 , 
and 0.00 
10 0 .16 , 0 .08 , and 0.00 0 . 83 , 0.16 
19 0.08 and 0.00 0.2 (streak) 
22 0.08 and 0.00 0 .15 , 0.00 

Countercurrent Distribution Studies on the N-Carbobenzoxy­
lated Crude B-Dihydrostreptomycin 
Determination of the Distribution Coefficient 
The solvent system used in this study consisted of 100 ml of 
redistilled 1-butanol and 100 ml of 5 percent p-toluenesulfonic acid 
monohydrate (Columbia Organic Chemicals) in distilled water. The two 
solvents were agitated for about 10 minutes in a 500-ml separatory 
funnel. A sample of 4-78 mg of the N-carbobenzoxylated crude B-dihydro 
streptomycin was added to the separatory funnel and the mixture was 
once again thoroughly agitated. On standing the two layers separated. 
The lower aqueous layer was treated with ion-exchange resin IRC 4-5 (OH 
phase) to a pH of 5 . 6 - 6 . 0 , the eluent was passed over a 50 ml column 
of IRC 4-5 (CI~ phase). The column was also washed with about 75 ml of 
water. The eluent was lyophilized and weighed 20k mg. 
The upper (organic) phase was evaporated to about 10 ml and was 
treated with IRC 4-5 (0H~ phase) and IRC 4-5 (CI~ phase) as above. The 
lyophilized residue weighed 197 mg. The distribution coefficient was 
thus 0 .97. 
The n.m.r. spectrum of the organic layer residue showed only 
15 percent carbobenzoxylation, compared with almost quantitative car-
bobenzoxylation of the residue from the water layer. 
Separation of the N-Carbobenzoxylated Crude B-Dihydrostreptomycin 
Using Countercurrent Distribution 
The solvent system consisted of an upper phase of 1 liter of 1 -
butanol equilibrated with 1 liter of 5 percent p-toluenesulfonic acid 
monohydrate. The two phases were separated. 
A ten-tube countercurrent distribution apparatus (each tube 
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capacity 50 ml) was employed. A sample (2.615 g) of the N-carbobenzo-
xylated crude p-dihydrostreptomycin preparation was dissolved in the 
lower phase and extracted with the upper phase. Ten upper phase frac­
tions, each measuring 50 ml, were collected and each fraction was con­
centrated to about 10 milliliters, neutralized with ion-exchange resin 
IRC 45 (OH phase), and finally passed over 25-30 ml columns of ion-
exchange resin IRC 45 (CI phase). The fractions were lyophilized and 
the weights recorded. A graph relation between the number and the 
weight of the fraction is given in Figure 4. 
The lower fractions were similarly concentrated, neutralized, 
and passed over ion-exchange resin IRC 45 (CI- phase) columns, and 
lyophilized. The weights of the fractions are given in Figure 4. 
The n.m.r. spectra of fractions 1 and 4 (lower phase) showed no 
aromatic protons, while fractions 2 and 8 (upper phase) showed quanti­
tative W-carbobenzoxylation„ 
The TLC analysis of the fractions was performed using microcry­
stalline cellulose plates (0 .25 mm thick) using a solvent system 1 -
butanolracetic acid:water ( 4 : 1 : 5 ) . Fractions 1 , 3 5 5 5 7 , and 9 of the 
lower and upper phases were analyzed. Two analyses were run for each 
fraction simultaneously, one of which was more highly loaded (three 
times the first application). The spots were visualized by spraying 
with Weber reagent. The R^ , values are given in Table 13. 
Characterization of Pure [3-Dihydrostreptomycin Trihydrochloride 
The 8-dihydrostreptomycin trihydrochloride showed the following 
infrared absorptions (potassium bromide pellet). 
Figure 5. N.m.r. Spectrum of Pure 8rDihydrostreptomycin 
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Table 13. TLC Analyses of Fractions from Countercurrent 
Distribution of Preparation from N-Carbobenzoxy-
lation of Crude (3-Dihydrostreptomycin 
N.B. A prime superscript indicated more highly loaded run. 
Upper Phase 
Fraction Number 
1 0 .25 , 0.60 
1 ' 0 . 2 1 , 0.58 
3 0 .25 , 0.53 
3 ' 0 .26 , 0.58 
5 0 .27 , 0.53 
5' 0 .23 , 0.58 
7 0 . 2 1 , 0.52 
7' . 0,22, 0.52 
9' 0 .25 , 0.50 
9' 0 . 2 2 , 0.50 
• Lower Phase 
Fraction Number 
1 0.29 
1 ' 0.29 
3 0 . 3 1 
3' 0 .31 
5 0.29 
5' 0.29 
7 0.28 
7' 0.28 
9 0.29 
9' 0.24 
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\ 3.0|j, (broad), 6.1(i(broad), 7.2(j, (weak, broad), 7.95M* (sharp), 
max 
9.2M, 9.8M, and 12.5M> among others. 
The optical rotation was [ a ] ^ = - 23 .3° (c_ 1 .2 , water) (lit, for 
a-dihydrostreptomycin trihydrochloride = - 88 .7 ° (c_ 1.0 water) ( 4 4 ) . 
Acid Hydrolysis of Pure g-Dihydrostreptomycin Trihydrochloride 
A sample of B-dihydrostreptomycin trihydrochloride ( l 4 l mg; 0.2 
millimole) was treated with 10 ml of IN sulfuric acid at 45° for 8 hours. 
White crystals appeared at the end of this period. The mixture was 
cooled for 4 hours in the refrigerator. The crystals were filtered, 
dried, and weighed 69 mg ( 0 .2 millimole). This material was identified 
as streptidine sulfate by comparison of its infrared spectrum with that 
of the authentic streptidine sulfate. 
The filtrate, after neutralization with ion-exchange resin IRC 45 
(OH phase) and elution over an ion-exchange resin, IRC 45 (CI phase), 
was lyophilized immediately. The resulting pale yellow glassy solid 
showed no sharp melting point and weighed 68 mg. Using thin-layer 
chromatographic analysis on microcrystalline cellulose plate, employing 
a l-butanol:acetic acidswater system in the ratio of 4 : 1 : 5 , the solid 
gave a spot with an R^ of 0 .35. A similar analysis with a-dihydrostrep-
tobiosamine showed an RTn of 0 .26. 
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CHAPTER III 
DISCUSSION 
The purpose of this research was to elucidate the structural 
differences in the a- and (3-streptomycin salts. The crystalline B -
streptomycin salts have been obtained by precipitating streptomycin as 
the tergitate (4-ethyl-l-3'-ethylpentyloctyl sulfate; tergitol 7-anionic 
is its sodium salt). On "aging" at neutral pH and at 5° for an extended 
period of time, this precipitate could be crystallized. This salt has 
been converted to crystalline chloride and bromide salts. The differ­
ences in the solubility properties of the corresponding a- and B-strep-
tomycin salts are striking. The B-streptomycin trichloride, unlike the 
a salt, is insoluble in methanol. The 8-streptomycin sulfate is in­
soluble in water, whereas the a-streptomycin sulfate is readily water 
soluble. The aging of crude streptomycin tergitate at 5° proceeded 
satisfactorily and optimum yields of crystallized tergitate were obtained 
after five days. The tergitol-7 anionic did not produce any crystalline 
tergitates (B-tergitates) if it was added rapidly to the streptomycin 
sulfate solution. The tergitol-7 anionic also appeared to decompose 
when left at room temperature for five to six months, as indicated by 
the darkening of its color. 
The potentially free aldehyde group in the streptose moiety of 
streptomycin cannot be detected spectroscopically, although the group 
has been reduced (to dihydrostreptomycin) and oxidized (to streptomycinic 
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acid (5,44). It had been suggested by earlier workers that this alde­
hyde group in streptomycin is involved in an internal hemiacetal" link­
age with one of the various hydroxyl groups or nitrogens of aminomethyl 
or guanidino functions. Young suggested that the a and the p forms of 
streptomycin are tautomers, and also that the most weakly basic group, 
i.e., the -NH-CH^ group, may be concerned in the "tautomerism" ( 26 ) . 
He, however, recorded no experimental evidence to substantiate this 
suggestion. 
Since the P- salts are more stable in acidic medium, it seems 
reasonable to believe that they possess the N-hemiacetal structure as 
proposed by Young. 
OH 
H 
C 
H 
+ : N - H 
I 
CH„ 
_
 c _ u — CH. 3 
H H 
In acid solution, the approach of hydronium ion toward the 
hemiacetal carbon atom is hindered because of the positive charge on 
the nitrogen. This would prevent the hydrolysis of the N-hemiacetal 
linkage. 
If such an N-hemiacetal structure was present in p-streptomycin 
5h 
salts, catalytic hydrogenation studies should provide useful information. 
If the C-N bond were hydrogenolyzed, a-dihydrostreptomycin would result; 
if the C-0 bond were hydrogenolyzed, a new tertiary amine (an oxazepine) 
would result. An example of this is the hydrogenation of dihydrostrepto-
biosamine hydrochloride which results in absorption of one mole of hydro­
gen. The product, when acetylated, did not give the expected heptaacetyl-
tetrahydrostreptobiosamine, but a base hydrochloride with the molecular 
formula C^H^Og^CH^CO)^ • HC1. The hydrogenated product, prior to 
acetylation, could not be hydrolyzed to N-methyl-L-glucosamine and was 
also found to be non-reducing (30). The reduced product was assigned 
the morpholine structure IX. 
R = -H IX 
R = -OH X 
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Prior to hydrogenolysis, the dihydrostreptobiosamine was assigned a 
similar structure X. The hydrogenolysis of the N-hemiacetal linkage 
proceeded selectively, cleaving the carbon-oxygen bond preferentially 
over the carbon-nitrogen bond. 
On the basis of this analogy and the earlier suggestion by 
Young, if the B-streptomycin salts have the N-hemiacetal structure, on 
catalytic hydrogenation they would be expected to yield a tertiary amine. 
Examination of Dreiding models of the streptomycin molecule reveals 
that N-hemiacetal formation with any of the guanidino nitrogen atoms 
results in a strained ring with severe non-bonding interactions. N-
Hemiacetal formation with the amino-methyl nitrogen results in no 
unusual interactions or strain; a seven-membered ring results. The 
structure of B-streptomycin salts after hydrogenolysis would be a 
tertiary amine (VII, R = H) and not dihydrostreptomycin. 
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When subjected to acid hydrolysis, streptidine and not N-methyl-
L-glucosamine should be the hydrolysis product. Similarly, if there is 
a hemiacetal linkage between the aldehyde group of streptose and any 
nitrogen.of the guanidino groups of streptidine (non-bonding interaction 
not withstanding), the catalytic hydrogenation should be expected to 
yield a compound containing a disubstituted guanidino group. On acid 
hydrolysis, such a compound would be expected to yield N-methyl-L-
glucosamine. 
The most conclusive approach toward the solution of this problem 
would be to establish the structure of a crystalline P-streptomycin 
salt by X-ray diffraction studies. Attempts were at first directed 
toward a trihydroiodide salt of p-streptomycin which had not been re­
ported in the literature. Attempts to prepare this salt by mixing a 
methanolic solution of calcium iodide and a concentrated methanolic 
solution of crystalline P-streptomycin tergitate proved futile, even 
when the mixture was kept at 0° for up to six months. A slight varia­
tion, employing sodium iodide in place of calcium iodide, met with a 
similar fate. The trihydrobromide salt had been reported in the litera­
ture and was used for X-ray diffraction studies. This salt gave rise 
to a diffuse pattern and it has been suggested that these crystalline 
salts are, in effect, liquid crystals, and hence unsuitable for X-ray 
diffraction studies (45). 
' Hydrogenolysis of P-streptomycin trihydrochloride, using freshly 
regenerated platinum oxide or 5 percent platinum on carbon as the 
catalyst and 75 percent acetic acid as the solvent, gave rise to a 
glassy white material after absorption of one equivalent of hydrogen. 
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This substance had no sharp melting point, and its specific rotation 
varied from preparation to preparation. However, it exhibited no 
mutarotation, gave a negative maltol test, and a negative Fehling test. 
On acid hydrolysis it gave a quantitative amount of streptidine and a 
water soluble basic compound. The latter, in the form of its 0- and 
N-trimethylsilyl ethers, by gas liquid chromatography, showed two major 
peaks in the ratio of about 1:3. The trimethylsilyl ethers of dihydro-
streptobiosamine, obtained from a-dihydrostreptomycin on similar analysis 
showed only one major peak, which had the same retention time as the 
smaller peak in the first case. 
Further attempts were directed at establishing the separate en­
tity of the hydrogenolysed B-streptomycin, hereinafter referred to as 
the crude B-dihydrostreptomycin preparation. 
The hypothesis of the N-hemiacetal formation between the aldehyde 
group and the aminomethyl nitrogen could be further confirmed if the 
hydrogenolyzed product was subjected to carbobenzoxylation under con­
ditions where only the aminomethyl nitrogen of a-dihydrostreptomycin is 
carbobenzoxylated. The procedure for this N-carbobenzoxylation was 
established using a-dihydrostreptomycin. The pH of the reaction was 
/ 
maintained between 8 .5 -10 .0 by addition of ion-exchange resin IR-400 
(OH phase). This solution of a-dihydrostreptomycin was next treated 
with about a five-fold excess of carbobenzoxy chloride (solvent free) 
for about 2 hours. After filtering the resin and removing the excess 
carbobenzoxy chloride by extraction with ether, the aqueous solution 
was converted to the chloride form by means of ion-exchange resin IRC 45 
(CI phase; washed to pH 3 . 5 - 4 . 0 ) . After lyophilization, a glassy white 
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solid resulted. The extent of carbobenzoxylation was determined by 
analysis of the n.m.r. .spectrum of the product. .The area of the peak 
given by the protons in the aromatic region (t2.7) and that of the C-
methyl doublet (t8.9) were in the ratio of 5 :3 , showing that essentially 
quantitative N-carbobenzoxylation of Qf-dihydrostreptomycin had resulted. 
When the crude B-dihydrostreptomycin was subjected to an exactly 
similar procedure for N-carbobenzoxylation, the extent of this N-carbo-
benzoxylation varied from preparation to preparation. In the initial 
stages of this work, using 5 percent platinum on carbon as the catalyst 
and 70 percent acetic acid as the solvent, l 8 to 32 percent N-carbo-
benzoxylation resulted from the crude p-dihydrostreptomycintrihydro-
chloride, thus, 82 to 68 percent of the 8-streptomycin had been converted 
to p-dihydrostreptomycin. This result indicates that p-streptomycin has 
structure VI and P-dihydrostreptomycin has structure VII. 
In the latter stages of this work, the catalyst (5 percent plati­
num on carbon) gave a product containing almost no P-dihydrostreptomycin 
(as indicated by almost quantitative N-carbobenzoxylation). Various 
other catalysts were used for this hydrogenolysis, but only platinum 
oxide proved satisfactory and gave 50 to 55 percent conversion to the 
P form. All these percentages were, of course, calculated by analyses 
of the n.m.r. spectrum of the carbobenzoxylated product by a comparison 
of the areas of the peaks corresponding to the C-methyl group and the 
protons in the aromatic region. 
Various crystalline salts of this preparation were prepared, 
and their physical properties were studied and compared with those of 
the corresponding salts of Q'-dihydrostreptomycin. No significant differ-
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ences were observed in the melting points or crystalline properties. 
Purification of the crude 3-dihydrostreptomycin was attempted first by 
converting it to a crystalline trihelianthate salt and then converting 
it back to the trihydrochloride by treatment with suitable ion-exchange 
resins. This procedure also did not give a pure B-dihydrostreptomycin 
(by n.m.r. analysis). 
Acetylation of the crude 0-dihydrostreptomycin would be expected 
to yield a mixture containing fully acetylated (hence neutral) a-dihydro­
streptomycin and fully acetylated (but basic, due to the unacetylated 
tertiary amine) B-dihydrostreptomycin. It thus might be possible to 
separate the two on a column of a suitable ion-exchange resin. The 
product obtained after acetylation was observed to be a complex mixture 
by TLC analysis. This approach was, therefore, abandoned. 
Benzolyation of the preparation did yield a mixture that was 
comparatively less complex. This product on elution using water-acetone 
over a column of ion-exchange resin IRC-50 (H+ phase) yielded a white 
residue, which on analysis by n.m.r. was found to be mainly benzoic acid. 
Since the preparation of B-dihydrostreptomycin contains two com­
ponents that are significantly different in structure, it might be 
possible to separate them using a sufficiently long Sephadex column. A 
portion of this preparation, when eluted over the Sephadex G-15 column 
(475 cm tall and 1.9 cm in diameter) with 0.013 M formic acid, did not 
show any separation. All the fractions showed protons in the aromatic 
region in their n.m.r. spectra. Only one peak was observed in the graph 
of mass versus fraction number. Another attempt was made with a similar 
column but using the W-carbobenzoxylated 3-dihydrostreptomycin preparation. 
6o 
The peak this time was observed to be broad; no separation of the 
components was achieved.-
Various other chromatographic techniques were next used to 
attempt this separation. Using silica gel as the adsorbant and aqueous 
solutions of sodium acetate and•ammonium acetate appeared to be a de­
sirable solvent system (46). However, employing various concentrations 
of the salts resulted in no separation for the 6-dihydrostreptomycin 
preparation or the N-carbobenzoxylated form of this preparation. Using 
paper chromatography (Whatman No. l) and l-butanol:acetic acid:water 
(2:l:l) as the solvent, the B-dihydrostreptomycin preparation showed 
two spots. When TLC plates using normal cellulose were used, the same 
solvent system again showed two spots. The separation of this prepara­
tion on a cellulose column under pressure was attempted. The mass 
versus fraction number graph did show two peaks but all fractions showed 
protons in the aromatic region in their n.m.r. spectra, thus indicating 
that no separation had been achieved. When the N-carbobenzoxy-B-dihydro-
streptomycin preparation was chromatographed on a similar cellulose 
column, no separation was achieved. 
Another attempt to separate this mixture was made using micro-
crystalline cellulose which had been reported to be very effective for 
separating disachharides, amino acids, etc. (47). Using 1-butanol: 
acetic acid:water (4:1:5), two spots were observed, one of which was 
more intense than the other. When this analysis was carried out on a 
preparative scale, the spots were not well separated and were diffuse. 
Both spots showed protons in the aromatic region of their n.m.r. spectra, 
although not to the same extent. This approach was abandoned. 
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Only partition methods had given any indication of separating to 
any extent the N-carbobenzoxylated form of crude B-dihydrostreptomycin 
preparation. A study of the partition coefficient of the above prepara­
tion between two immiscible liquid phases was undertaken. The mixture 
1-butanol and 5 percent aqueous solution of p-toluenesulfonic acid (which 
had been pre-equiliberated) was selected as the liquid system for these 
studies. A sample that had only 15 percent conversion to the B-form 
when partitioned between these solvents showed a distribution coefficient 
of 0 .97 . A more significant observation was that the material recovered 
from the aqueous phase showed the presence of 75 percent of the B-form, 
while the material from the 1-butanol layer had no B-form at all. 
When this partition was carried out using a Craig countercurrent 
distribution apparatus, the fractions from the lower phase showed no 
protons in the aromatic region by their n.m.r. spectra and showed only 
one spot by microcrystalline cellulose TLC plates using 1-butanol:acetic 
acidrwater ( 4 :1 :5 ) as the solvent system. The butanol layer fractions 
showed protons in the aromatic region (n.m.r. spectra) and two spots by 
TLC analyses. 
The pure B-dihydrostreptomycin obtained by this separation, upon 
acid hydrolysis, yielded streptidine sulfate which was identified by 
its solubility behavior, by comparison' of its value with that of 
authentic streptidine sulfate, and by a comparison of the infrared spectra 
of the two. 
The other product of hydrolysis, 8-dihydrostreptobiosamine, when 
compared with authentic a-dihydros trepbiosamine, showed different R^ , 
values in at least one solvent system. The optical rotation of pure 
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p-dihydrostreptomycin was observed to be -23 .2° (c_ 1.2 water); a-dihy-
drostreptomycin has a specific rotation of -88° (c_ 1.0 water) (44). A 
sample of crude p-dihydrostreptomycin (n.m.r. assay of its N-carbobenzoxy 
form revealed 25 percent of a-dihydrostreptomycin) was found to be 30 
percent as active as a streptomycin standard, against Bacillus subtlis 
in vitro. It suggested that the pure p-dihydrostreptomycin had a low 
order of antibacterial potency against Bacillus subtlis. Both strepto­
mycin and dihydrostreptomycin have equivalent potency values against this 
organism (48). Pure P-dihydrostreptomycin, when tested against a sensi­
tive strain of B^ subtlis and S. pyrogenes showed no biological activity. 
Alpha-dihydrostreptomycin showed marked activity against these bac­
teria (49). 
Suggestions'for Further Work 
The X-ray diffraction pattern of p-streptomycin sulfate has been 
reported to be different from that of the corresponding bromide. It 
is suggested that a selenate of p-streptomycin be used for X-ray dif­
fraction studies of this molecule. This study would also confirm the 
stereochemistry of N-H bond in the oxazepine part of the molecule. 
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